Displaying 381 - 400 of 1583
Statement of Chairman Joseph Simons, Commissioner Noah Joshua Phillips, and Commissioner Christine S. Wilson Regarding Joint Department of Justice and Federal Trade Commission Vertical Merger Guidelines
Date
By
Joseph J. Simons, Former Chairman;
Noah Joshua Phillips, Former Commissioner;
Christine S. Wilson, Former Commissioner
Matter Number
P810034
Dissenting Statement of Commissioner Rohit Chopra Regarding the Publication of the Vertical Merger Guidelines
Date
By
Rohit Chopra, Former Commissioner
Matter Number
P810034
Dissenting Statement of Commissioner Rebecca Kelly Slaughter In Re FTC-DOJ Vertical Merger Guidelines
Date
By
Rebecca Kelly Slaughter, Commissioner
Matter Number
P810034
FTC and DOJ Issue Antitrust Guidelines for Evaluating Vertical Mergers
Date
The Federal Trade Commission (“FTC”) and the Department of Justice (“DOJ” or “Department”) issued today new Vertical Merger Guidelines that outline how the federal antitrust agencies evaluate the...
FTC Requires Casino Operators Eldorado Resorts, Inc. and Caesars Entertainment Corporation to Divest Assets in Two Local Markets as a Condition of Merger
Date
The Federal Trade Commission will require casino operator Eldorado Resorts, Inc. to divest casino-related assets in the South Lake Tahoe area of Nevada, and the Bossier City-Shreveport area of...
FTC Requires Divestitures as Condition of Tri Star Energy, LLC’s Acquisition of Certain Assets of Hollingsworth Oil Company, Inc., C & H Properties, and Ronald L. Hollingsworth
Date
Tri Star Energy, LLC and Hollingsworth Oil Company, Inc., C & H Properties, and Ronald L. Hollingsworth have agreed to divest , retail fuel assets to settle charges that Tri Star’s proposed...
Federal Register Notice
Granting of Requests for Early Termination of the Waiting Period Under the Premerger Notification Rules (May 2020)
Date
FTC Approves Final Order Settling Charges that VieVu’s Former Parent Company Safariland Entered into Anticompetitive Agreements with Body-Worn Camera Systems Seller Axon
Date
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Safariland, LLC, which manufactures and sells equipment for the law-enforcement...
FTC Approves Final Order Settling Charges that Danaher Corporation’s Acquisition of GE Biopharma Was Anticompetitive
Date
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Danaher Corporation’s acquisition of GE Biopharma would likely reduce competition in...
FTC Approves Final Order Imposing Conditions on Össur Hf’s Acquisition of College Park Industries, Inc.
Date
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Össur Hf’s proposed acquisition of College Park Industries, Inc. would violate federal...
Össur Hf. and College Park Industries, In the Matter of
Össur Hf and College Park Industries, Inc., both makers of prosthetic limbs, have agreed to divest College Park’s myoelectric elbow business to settle Federal Trade Commission charges that Össur’s proposed acquisition of College Park would violate federal antitrust law.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
191 0177
Case Status
Pending
Federal Register Notice
Granting of Requests for Early Termination of the Waiting Period Under the Premerger Notification Rules (April 2020)
Date
Federal Register Notice
AbbVie Inc. and Allergan plc; Analysis of Consent Order To Aid Public Comment
Date
Statement of Chairman Joseph J. Simons, Commissioner Noah J. Phillips and Commissioner Christine S. Wilson Concerning the Proposed Acquisition of Allergan plc by AbbVie Inc.
Date
By
Joseph J. Simons, Former Chairman;
Noah Joshua Phillips, Former Commissioner;
Christine S. Wilson, Former Commissioner
Matter Number
191 0169
FTC Imposes Conditions on AbbVie Inc.’s Acquisition of Allergan plc
Date
Pharmaceutical companies AbbVie Inc. and Allergan plc have agreed to divest assets to settle Federal Trade Commission charges that AbbVie’s proposed $63 billion acquisition of Allergan would violate...
Dissenting Statement of Commissioner Rohit Chopra In the Matter of AbbVie Inc. and Allergan plc
Date
By
Rohit Chopra, Former Commissioner
Matter Number
191 0169
Dissenting Statement of Commissioner Rebecca Kelly Slaughter Regarding the Proposed Acquisition of Allergan plc by AbbVie Inc.
Date
By
Rebecca Kelly Slaughter, Commissioner
Matter Number
191 0169
Displaying 381 - 400 of 1583